Uniparental disomy of Chromosome 2 unmasks new ITGA6 recessive mutation and results in a lethal junctional epidermolysis bullosa in a newborn by Higgins, Rebecca et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2020
Uniparental disomy of Chromosome 2 unmasks new ITGA6 recessive
mutation and results in a lethal junctional epidermolysis bullosa in a
newborn
Higgins, Rebecca ; Jensen, Annika N ; Wachstein, Julian ; Bruckner-Tuderman, Leena ; Spiegel, Roland
; Traber, Hubert ; Achermann, Josef ; Schaller, Martin ; Fehrenbacher, Birgit ; Röcken, Martin ;
Ignatova, Desislava ; Chang, Yun-Tsan ; Fischer, Tina ; Schwieger-Briel, Agnes E ; French, Lars E ;
Hoetzenecker, Wolfram ; Hornung, René ; Malzacher, Andreas ; Cozzio, Antonio ; Navarini, Alexander ;
Has, Cristina ; Guenova, Emmanuella
DOI: https://doi.org/10.2340/00015555-3313
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-183417
Journal Article
Published Version
Originally published at:
Higgins, Rebecca; Jensen, Annika N; Wachstein, Julian; Bruckner-Tuderman, Leena; Spiegel, Roland;
Traber, Hubert; Achermann, Josef; Schaller, Martin; Fehrenbacher, Birgit; Röcken, Martin; Ignatova,
Desislava; Chang, Yun-Tsan; Fischer, Tina; Schwieger-Briel, Agnes E; French, Lars E; Hoetzenecker,
Wolfram; Hornung, René; Malzacher, Andreas; Cozzio, Antonio; Navarini, Alexander; Has, Cristina;
Guenova, Emmanuella (2020). Uniparental disomy of Chromosome 2 unmasks new ITGA6 recessive mu-
tation and results in a lethal junctional epidermolysis bullosa in a newborn. Acta Dermato-Venereologica,
100(1):adv00041.
DOI: https://doi.org/10.2340/00015555-3313
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
SHORT COMMUNICATION
Acta Derm Venereol 2020; 100: adv00041
This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta
Journal Compilation © 2020 Acta Dermato-Venereologica.
doi: 10.2340/00015555-3313
1/3
1https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3313
Epidermolysis bullosa (EB) is a group of genetic disorders 
characterized by fragility of skin and mucosa. The majo-
rity of subtypes of EB result from malfunction of anchor 
proteins of the basal membrane zone (BMZ). Based on 
the level of blister formation, EB is classified into 4 major 
forms: EB simplex, junctional EB, dystrophic EB, and 
Kindler syndrome (Fig. S11). 
Junctional EB (JEB) is caused by mutations in genes 
encoding for components of the lamina lucida, e.g. integrin 
beta 4 (ITGB4), integrin alpha 6 (ITGA6), laminin-332 
genes (LAMA3, LAMB3 and LAMC2), etc. One specific 
type of JEB with mutations in α6β4 integrin presents with 
skin fragility in association with pyloric atresia. JEB is 
inherited only in a recessive manner. 
Trisomy 2 mostly results in first trimester pregnancy loss; 
it is compatible with life exclusively in mosaic states or 
when restricted to the placental tissues. Common in utero 
indications of mosaic trisomy 2 are oligohydramnios and 
poor foetal growth. High trisomic levels in placenta and the 
foetus can result in abnormal and fatal phenotypes (1). Phe-
notypes of uniparental disomy of chromosome 2 (UPD2) 
resulting in trisomy mosaicism have described phenotypes, 
such as genital hypoplasia, intrauterinal growth retardation 
(IUGR) and oligohydramnios. Exceptional cases of full 
UPD2 have been described in healthy individuals (2, 3).
We report here a case of a newborn with JEB resulting 
from a previously unknown homozygous mutation leading 
to a premature termination codon in the gene encoding for 
ITGA6. The loss of heterozygosity occurred in the setting 
of an exclusive maternal UPD2.
METHODS (see Appendix S11)
CASE REPORT AND RESULTS
A 28-year-old healthy primigravida underwent amniocentesis 
after ultrasonography performed at 31 weeks of gestation revealed 
foetal abnormalities (growth retardation, pyloric atresia with po-
lyhydramnios and a fluid-filled stomach, and complex lower-limb 
anomalies with disproportional long-bone shortening and aplasia 
of the foot structures). 
Amniotic fluid was submitted for cytogenetic analysis and 
array-based comparative genomic hybridization (CGH) testing. 
Chromosomal analysis and metaphase fluorescence in situ hybri-
dization (FISH) for chromosome 2 revealed a rare trisomy 2 in 
12–15% of all cells in the amniotic fluid with an aberrant 47, XX +2 
(2)/ 46, XX karyotype, confirmed by array-based CGH (Fig. 1A). 
Due to foetal growth arrest and polyhydramnios, labour was 
induced at 37 weeks’ gestation. The newborn was small for ge-
stational age (3 standard deviations (SD) below 1st percentile). 
Multiple blisters of the skin on the trunk, head, and umbilical cord 
could be observed, as well as aplasia cutis on all 4 limbs (Fig. 1B). 
The infant died after 5 days.
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Fig. 1. Prenatal and clinical findings. (A) Amniocentesis results at 31 
weeks’ gestation. Chromosomal analysis with karyotyping and metaphase 
fluorescence in situ hybridization (FISH) for chromosome 2 shows trisomy 
2 in 12–15% of all cells in the amniotic fluid. Aberrant 47, XX +2 (2)/ 
46, XX karyotype. The comparative genomic hybridization (CGH) array 
distribution indicates a higher amount of Chr 2 in the patient than in the 
reference DNA. (B) Clinical images of the patient 1 day after birth with 
skin aplasia of the left leg, blister on the right side of the head and ear 
and new blisters following minor trauma (touch) on the torso and left arm.
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Histology revealed a subepidermal blister without inflammation. 
The basal membrane, visualzed by staining for collagen type IV, 
remained firmly attached to the base of the blister cavity. The ul-
trastructural sites of the blister formation could be detected within 
the lamina lucida. There was a decrease in the transmembrane 
proteins of the hemidesmosomal plate. Immunofluorescence map-
ping disclosed junctional splitting and loss of immunoreactivity 
for the integrin a6/ß4 (Fig. S2A–E1). 
Whole exome sequencing (WES) ruled out non-paternity and 
identified a novel frame-shift mutation in the ITGA6 gene for inte-
grin α6 (patient homozygous, mother heterozygous, and mutation 
absent from the father) and a missense variant in the COL4A4 gene 
(patient homozygous, mother heterozygous, and mutation absent 
from the father). Collagen type IV protein was unaffected both 
immunohistochemically (Fig. S2B1) and on immunofluorescence 
mapping (Fig. S2E1); however, the high pathogenicity of the mu-
tation indicates a possible clinical relevance. COL4A4 mutations 
have not previously been described in any EB subtype. 
The mutation in ITGA6 has not been reported previously. The 
CADD Phred score of 35 for the ITGA6 mutation places it in the 
top 0.1% of altering mutations. This novel frame-shift mutation 
in the ITGA6 gene accounted for the lack of integrina6 protein 
in the patient’s skin and was the pivotal feature to diagnose an 
autosomal recessive inherited junctional epidermolysis bullosa 
with pyloric atresia (JEB-PA). In confirmation of the results of the 
immunofluorescence mapping (Fig. S2E1) and the WES, Sanger se-
quencing disclosed a homozygous insertion c.2843_2844dupCG, 
in exon 22 of the JEB-associated gene ITGA6 (chr2exon22 
c.2843_2844dupCG) (Fig. S3A–B1). The 2-nucleotide insertion 
resulted in a frame-shift mutation and a premature stop codon and 
termination of translation p.Ser949Argfs*15. The mutation was 
located on chromosome 2, an extra copy of which (trisomy 2) we 
had identified previously in 12–15% of all cells in the amniotic 
fluid during the prenatal diagnostic at 31 weeks’ gestation.
At birth, the loss of evidence for persistent trisomy 2, and the 
clinical manifestation of an autosomal recessive disease in a child 
born to a wild-type father and a heterozygous mother, suggests a 
complete chromosomic rescue and unipaternal (maternal or paternal 
only) inheritance of the genes located on the affected chromosome 2.
For an accurate evaluation of the suspected UPD2, postnatal 
segregation analysis with chromosome 2-specific short tandem 
repeat (STR) markers was performed. This exhibited exclusive 
maternal and a lack of any paternal inheritance of chromosome 2 
in the newborn, the maternal uniparental isodisomy 2, following 
the complete chromosomic rescue of trisomy 2, unmasked in a 
homozygous setting the novel chr2exon22 c.2843_2844dupCG 
mutation in the ITAG6 gene and resulted in the clinical manifesta-
tion of a lethal ITGA6-related JEB-PA.
DISCUSSION
Foetal trisomy can occur due to meiotic non-disjunction 
events in either parent (4). Trisomy rescue is a rare phe-
nomenon whereby the zygote, with 3 copies of a chromo-
some, spontaneously loses 1 copy, resulting in a diploid 
state. Indeed, any copy of the chromosome can be lost, 
potentially retaining both copies from the faulty gamete, 
resulting in a UPD (Fig. S41), identical alleles (isodisomy) 
of multiple genes, and may be the cause of the clinical ma-
nifestation of imprinting or recessive disorders. The rate 
of segmental UPD is estimated as 1 per 3806 chromosome 
pairs (0.026%) (5). Whole-chromosome UPD is very rare.
A few cases of JEB have been described with a UPD-
based inheritance pattern. Mutations in laminin-332 are 
associated with the severe subtype of severe generalized 
(Herlitz) JEB (6). Homozygous mutations in 2 subunits 
of laminin 332 (LAMB3 and LAMC2) caused by maternal 
and paternal UPD of chromosome 1 have been reported a 
few times (7–11). Inheritance of JEB with pyloric atresia 
through a UPD event has been described (12). 
ITGA6 is an important component in embryogenesis 
with roles in endoderm migration and nervous system 
development. It forms a heterodimer with ITGB4 (α6β4) 
in the BMZ.  In JEB the ultrastructure of hemidesmoso-
mes is abnormal, and several mutations in ITGA6 and 
ITGB4 have been reported (13). Some mutations result 
in less severe phenotypes with longer survival rates; 
hence the characterization of all ITGA6 and ITGB4 mu-
tations is important to assist patient counselling (14). In 
the case reported here, the newly detected chr2exon22 
c.2843_2844dupCG mutation is strongly indicative of a 
severe phenotype with a short survival.
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